Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
Authors
Keywords
-
Journal
JOURNAL OF NEUROSURGERY
Volume 121, Issue 3, Pages 543-553
Publisher
Journal of Neurosurgery Publishing Group (JNSPG)
Online
2014-07-04
DOI
10.3171/2014.5.jns132392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice
- (2013) Luis A. Sanchez-Perez et al. PLoS One
- Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
- (2013) Trine Zeeberg Iversen et al. OncoImmunology
- Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors
- (2012) Shingo Takano et al. JOURNAL OF NEURO-ONCOLOGY
- Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery
- (2012) Walter Stummer et al. JOURNAL OF NEURO-ONCOLOGY
- Monoclonal antibody blockade of IL-2 receptor during lymphopenia selectively depletes regulatory T cells in mice and humans
- (2011) D. A. Mitchell et al. BLOOD
- Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma
- (2011) Yoshihiro Muragaki et al. JOURNAL OF NEUROSURGERY
- Pathological Changes After Autologous Formalin-Fixed Tumor Vaccine Therapy Combined With Temozolomide for Glioblastoma
- (2011) Noriaki SAKAMOTO et al. NEUROLOGIA MEDICO-CHIRURGICA
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial
- (2010) Il Han Kim et al. JOURNAL OF NEURO-ONCOLOGY
- Low Peripheral Lymphocyte Count Before Focal Radiotherapy Plus Concomitant Temozolomide Predicts Severe Lymphopenia During Malignant Glioma Treatment
- (2010) Eiichi ISHIKAWA et al. NEUROLOGIA MEDICO-CHIRURGICA
- Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model
- (2009) T.-G. Kim et al. Clinical and Vaccine Immunology
- Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma
- (2009) Jennifer L. Clarke et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Randomized Study of Postoperative Radiotherapy and Simultaneous Temozolomide without Adjuvant Chemotherapy for Glioblastoma
- (2008) Martin Kocher et al. STRAHLENTHERAPIE UND ONKOLOGIE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More